941 related articles for article (PubMed ID: 23338126)
1. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
2. Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways.
Xu W; Wu W; Chen J; Guo R; Lin J; Liao X; Feng J
Int J Mol Med; 2013 Oct; 32(4):917-25. PubMed ID: 23912965
[TBL] [Abstract][Full Text] [Related]
3. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
[TBL] [Abstract][Full Text] [Related]
4. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
[TBL] [Abstract][Full Text] [Related]
5. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways.
Xu W; Chen J; Lin J; Liu D; Mo L; Pan W; Feng J; Wu W; Zheng D
Int J Mol Med; 2015 Jan; 35(1):177-86. PubMed ID: 25412187
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
Liu MH; Lin XL; Zhang Y; He J; Tan TP; Wu SJ; Liu J; Tian W; Chen L; Yu S; Li J; Yuan C
Mol Med Rep; 2015 Nov; 12(5):6841-8. PubMed ID: 26299281
[TBL] [Abstract][Full Text] [Related]
8. Exogenous hydrogen sulfide alleviates high glucose-induced cardiotoxicity via inhibition of leptin signaling in H9c2 cells.
Zhuang XD; Hu X; Long M; Dong XB; Liu DH; Liao XX
Mol Cell Biochem; 2014 Jun; 391(1-2):147-55. PubMed ID: 24687304
[TBL] [Abstract][Full Text] [Related]
9. ATP-sensitive K⁺ channels contribute to the protective effects of exogenous hydrogen sulfide against high glucose-induced injury in H9c2 cardiac cells.
Liang W; Chen J; Mo L; Ke X; Zhang W; Zheng D; Pan W; Wu S; Feng J; Song M; Liao X
Int J Mol Med; 2016 Mar; 37(3):763-72. PubMed ID: 26820501
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells.
Chen J; Mo H; Guo R; You Q; Huang R; Wu K
Int J Mol Med; 2014 Mar; 33(3):605-12. PubMed ID: 24399619
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide attenuates doxorubicin‑induced cardiotoxicity by inhibiting calreticulin expression in H9c2 cells.
Liu MH; Zhang Y; Lin XL; He J; Tan TP; Wu SJ; Yu S; Chen L; Chen YD; Fu HY; Yuan C; Li J
Mol Med Rep; 2015 Oct; 12(4):5197-202. PubMed ID: 26134131
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress.
Wang XY; Yang CT; Zheng DD; Mo LQ; Lan AP; Yang ZL; Hu F; Chen PX; Liao XX; Feng JQ
Mol Cell Biochem; 2012 Apr; 363(1-2):419-26. PubMed ID: 22203419
[TBL] [Abstract][Full Text] [Related]
13. Exogenous hydrogen sulfide ameliorates high glucose-induced myocardial injury & inflammation via the CIRP-MAPK signaling pathway in H9c2 cardiac cells.
Zhao HL; Wu BQ; Luo Y; Zhang WY; Hao YL; Liang JJ; Fang F; Liu W; Chen XH
Life Sci; 2018 Sep; 208():315-324. PubMed ID: 29857073
[TBL] [Abstract][Full Text] [Related]
14. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
15. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
17. Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxia-induced injury in H9c2 cardiac myocytes.
Yang Z; Yang C; Xiao L; Liao X; Lan A; Wang X; Guo R; Chen P; Hu C; Feng J
Int J Mol Med; 2011 Sep; 28(3):397-403. PubMed ID: 21519787
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells.
Liu MH; Lin XL; Yuan C; He J; Tan TP; Wu SJ; Yu S; Chen L; Liu J; Tian W; Chen YD; Fu HY; Li J; Zhang Y
Mol Med Rep; 2016 Jan; 13(1):367-72. PubMed ID: 26573464
[TBL] [Abstract][Full Text] [Related]
19. Exogenous hydrogen sulfide protects against high glucose‑induced inflammation and cytotoxicity in H9c2 cardiac cells.
Huang Z; Dong X; Zhuang X; Hu X; Wang L; Liao X
Mol Med Rep; 2016 Nov; 14(5):4911-4917. PubMed ID: 27748941
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells.
Lan A; Liao X; Mo L; Yang C; Yang Z; Wang X; Hu F; Chen P; Feng J; Zheng D; Xiao L
PLoS One; 2011; 6(10):e25921. PubMed ID: 21998720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
